Early treatment and treat to target lead to early intensive therapy in many IBD patients. This is associated with cost, safety and quality of life issue. Treatment de-escalation is thus a logical option to discuss with the patients. The Crohn’s & Colitis Foundation and ECCO have teamed up to bring you key thought leaders from either side of the Atlantic to discuss de-escalation of therapy methodology.
Crohn's Colitis Professional
De-escalation in IBD Therapy
7
- Host: Bincy P. Abraham, MD, MS
- Guest: Jessica Allegretti, MD, MPH
- Guest: Edouard Louis, MD, PhD
Early treatment and treat to target lead to early intensive therapy in many IBD patients.
Facebook Comments